Nathan Shankar

3.7k total citations · 1 hit paper
44 papers, 2.9k citations indexed

About

Nathan Shankar is a scholar working on Infectious Diseases, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Nathan Shankar has authored 44 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 15 papers in Molecular Biology and 11 papers in Clinical Biochemistry. Recurrent topics in Nathan Shankar's work include Antimicrobial Resistance in Staphylococcus (34 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Bacterial biofilms and quorum sensing (9 papers). Nathan Shankar is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (34 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Bacterial biofilms and quorum sensing (9 papers). Nathan Shankar collaborates with scholars based in United States, France and Netherlands. Nathan Shankar's co-authors include Arto S. Baghdayan, Michael S. Gilmore, Gilmore Ms, Yasuyoshi Ike, Clewell Db, Jun Zou, Phillip S. Coburn, David E. Johnson, Cinthia Drachenberg and C. Virginia Lockatell and has published in prestigious journals such as Nature, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Nathan Shankar

43 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enterococci: From Commensals to Leading Causes of Drug Resistant Infection

2014 669 citations Gilmore Ms, Clewell Db et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathan Shankar United States	24	1.7k	1.2k	661	577	486	44	2.9k
Kátia Regina Netto dos Santos Brazil	39	1.6k 1.0×	1.5k 1.2×	887 1.3×	500 0.9×	474 1.0×	160	4.5k
Jean-Christophe Giárd France	36	1.2k 0.7×	1.4k 1.1×	416 0.6×	757 1.3×	265 0.5×	88	3.3k
Arto S. Baghdayan United States	16	1.2k 0.7×	804 0.7×	468 0.7×	359 0.6×	357 0.7×	17	1.9k
Yasuyoshi Ike Japan	35	1.9k 1.1×	1.8k 1.5×	690 1.0×	1.1k 1.9×	436 0.9×	94	4.0k
François J. Picard Canada	31	1.8k 1.1×	1.5k 1.2×	1.1k 1.6×	526 0.9×	443 0.9×	49	3.8k
Lúcia Martins Teixeira Brazil	33	964 0.6×	742 0.6×	559 0.8×	579 1.0×	775 1.6×	148	3.3k
Mohammad Emaneini Iran	31	1.2k 0.7×	1.3k 1.1×	704 1.1×	182 0.3×	255 0.5×	136	2.8k
Anne Tristan France	31	3.4k 2.0×	2.2k 1.8×	1.1k 1.6×	398 0.7×	731 1.5×	122	4.9k
Srdjan Stepanović Serbia	15	1.2k 0.7×	2.4k 2.0×	407 0.6×	932 1.6×	165 0.3×	23	4.5k
Slade O. Jensen Australia	33	1.5k 0.9×	1.8k 1.5×	768 1.2×	365 0.6×	401 0.8×	78	4.7k

Countries citing papers authored by Nathan Shankar

Since Specialization

Citations

This map shows the geographic impact of Nathan Shankar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Shankar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Shankar more than expected).

Fields of papers citing papers by Nathan Shankar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Shankar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Shankar. The network helps show where Nathan Shankar may publish in the future.

Co-authorship network of co-authors of Nathan Shankar

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Shankar. A scholar is included among the top collaborators of Nathan Shankar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Shankar. Nathan Shankar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shankar, Nathan, Amaravadhi Harikishore, Ragothaman M. Yennamalli, et al.. (2025). SA-XV, a 15-amino acid fragment of host defense peptide S100A12, targets mitochondria and is protective against fungal infections. Journal of Biological Chemistry. 301(10). 110743–110743.

Garza, Kimberly B., Jennifer L. Bacci, Nitesh K. Kunda, et al.. (2021). Building Implementation Science Capacity in Academic Pharmacy: Report of the 2020-2021 AACP Research and Graduate Affairs Committee. American Journal of Pharmaceutical Education. 85(10). 8718–8718. 5 indexed citations

Zou, Jun & Nathan Shankar. (2015). Roles of TLR/MyD88/MAPK/NF-κB Signaling Pathways in the Regulation of Phagocytosis and Proinflammatory Cytokine Expression in Response to E. faecalis Infection. PLoS ONE. 10(8). e0136947–e0136947. 64 indexed citations

Zou, Jun & Nathan Shankar. (2014). Enterococcus faecalis Infection Activates Phosphatidylinositol 3-Kinase Signaling To Block Apoptotic Cell Death in Macrophages. Infection and Immunity. 82(12). 5132–5142. 33 indexed citations

Ms, Gilmore, Clewell Db, Yasuyoshi Ike, & Nathan Shankar. (2014). Enterococci as Indicators of Environmental Fecal Contamination -- Enterococci: From Commensals to Leading Causes of Drug Resistant Infection. 9 indexed citations

Ms, Gilmore, Clewell Db, Yasuyoshi Ike, & Nathan Shankar. (2014). Enterococcal Infection—Treatment and Antibiotic Resistance -- Enterococci: From Commensals to Leading Causes of Drug Resistant Infection. 36 indexed citations

Garsin, Danielle A., Kristi L. Frank, Frederick M. Ausubel, et al.. (2014). Pathogenesis and Models of Enterococcal Infection. 26 indexed citations

Zou, Jun, Arto S. Baghdayan, Sarah J. Payne, & Nathan Shankar. (2014). A TIR Domain Protein from E. faecalis Attenuates MyD88-Mediated Signaling and NF-κB Activation. PLoS ONE. 9(11). e112010–e112010. 24 indexed citations

Ms, Gilmore, Clewell Db, Yasuyoshi Ike, & Nathan Shankar. (2014). Enterococcus Diversity, Origins in Nature, and Gut Colonization -- Enterococci: From Commensals to Leading Causes of Drug Resistant Infection. 39 indexed citations

10.

Baghdayan, Arto S., et al.. (2012). Biofilm and planktonicEnterococcus faecaliselicit different responses from host phagocytesin vitro. FEMS Immunology & Medical Microbiology. 65(2). 270–282. 43 indexed citations

11.

Awasthi, Vibhudutta, et al.. (2010). In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine. BMC Immunology. 11(1). 17 indexed citations

12.

Coburn, Phillip S., et al.. (2010). A novel conjugative plasmid from Enterococcus faecalis E99 enhances resistance to ultraviolet radiation. Plasmid. 64(1). 18–25. 18 indexed citations

13.

Broedel-Zaugg, Kimberly, Shauna M. Buring, Nathan Shankar, et al.. (2008). Academic Pharmacy Administrators' Perceptions of Core Requirements for Entry Into Professional Pharmacy Programs. American Journal of Pharmaceutical Education. 72(3). 52–52. 21 indexed citations

14.

Dozmorov, Mikhail G., Kimberly D. Kyker, Ricardo Saban, et al.. (2007). Systems biology approach for mapping the response of human urothelial cells to infection by Enterococcus faecalis. BMC Bioinformatics. 8(S7). S2–S2. 14 indexed citations

15.

Shankar, Nathan, Phillip S. Coburn, Chris M. Pillar, Wolfgang Haas, & Michael S. Gilmore. (2004). Enterococcal cytolysin: activities and association with other virulence traits in a pathogenicity island. International Journal of Medical Microbiology. 293(7-8). 609–618. 46 indexed citations

16.

Baghdayan, Arto S., et al.. (2004). Enterococcal Surface Protein, Esp, Enhances Biofilm Formation by Enterococcus faecalis. Infection and Immunity. 72(10). 6032–6039. 238 indexed citations

17.

Pultz, Nicole J., Nathan Shankar, Arto S. Baghdayan, & Curtis J. Donskey. (2004). Enterococcal surface protein Esp does not facilitate intestinal colonization or translocation ofEnterococcus faecalisin clindamycin-treated mice. FEMS Microbiology Letters. 242(2). 217–219. 20 indexed citations

18.

Baghdayan, Arto S., et al.. (2003). Pathogenic enterococci: new developments in the 21st century. Cellular and Molecular Life Sciences. 60(12). 2622–2636. 134 indexed citations

19.

Archimbaud, Christine, Nathan Shankar, Christiane Forestier, et al.. (2002). In vitro adhesive properties and virulence factors of Enterococcus faecalis strains. Research in Microbiology. 153(2). 75–80. 83 indexed citations

20.

Vergis, Emanuel N., Nathan Shankar, Joseph W. Chow, et al.. (2002). Association between the Presence of Enterococcal Virulence Factors Gelatinase, Hemolysin, and Enterococcal Surface Protein and Mortality among Patients with Bacteremia Due toEnterococcus faecalis. Clinical Infectious Diseases. 35(5). 570–575. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact